Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Our aim in this observational study was to evaluate the feasibility of a multiphasic screening project for the detection and treatment of mood and anxiety disorders among cancer patients in a natural setting. One hundred sixty-five patients with cancer, consecutively admitted to the Oncology Division of San Camillo-Forlanini Hospital, were recruited to the study. All patients had solid tumors; the majority of them were colon, breast, and lung cancers. All patients completed the Hospital Anxiety and Depression Scale (HADS). Patients screened as positive were administered the following instruments by a psychiatrist: the Structured Clinical Interview for DSM-IV (SCID-I), the Beck Depression Inventory (BDI), the Hamilton Anxiety Rating Scale (HARS), and a validated scale for the rapid dimensional assessment of psychopathology (SVARAD). The BDI, HARS, and SVARAD were administered again at 4 and 10 weeks to all treated patients. Out of 45 patients administered the SCID-I, 37 had a mood or anxiety disorder. Adjustment disorders were identified in 20 patients, depressive disorders in 14, and anxiety disorders in three patients. Most patients were prescribed psychotropic medications: mirtazapine was prescribed to 15 patients, citalopram to 13 patients, and escitalopram to four patients. A significant improvement in symptoms of depression and anxiety was observed on all measures (P<.001). Although the design of the study prevents any firm conclusions about effectiveness, this study suggests that including psychiatric expertise in an oncology division is feasible and may lead to improved detection and treatment of psychiatric disorders among cancer patients. Further randomized trials are needed to elaborate on our findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER
Spiegel, D., Kraemer, H., Bloom, J., & Gottheil, E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91551-1 · Cited by 2,353
The prevalence of psychiatric disorders among cancer patients
Derogatis, L. R. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330300035030 · Cited by 1,575
Screening for Adjustment Disorders and Major Depressive Disorders in Cancer In-Patients
Razavi, D., Delvaux, N., Farvacques, C., & Robaye, E. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.156.1.79 · Cited by 514 · cited 3×
“, 2004] or adjustment disorders in patients with cancer [Atesci et al., 2004; Grassi et al., 1987; Keller et al., 2004; Razavi et al., 1990].”
BackgroundResultPsychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis
Kissane, D. W., Grabsch, B., Love, A., Clarke, D. M., Bloch, S., & Smith, G. C. (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01358.x · Cited by 337 · cited 1×
“A study of patients with breast cancer estimated the prevalence of psychiatric disorders, using the Structural Clinical Interview for DSM-IV (SCID), to be 45% regardless of metastatic status [Kissane et al., 2004].”
MethodPilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.
Loprinzi, C. L., Pisansky, T. M., Fonseca, R., Sloan, J. A., Zahasky, K. M., Quella, S. K., Novotny, P. J., Rummans, T. A., Dumesic, D. A., & Perez, E. A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2377 · Cited by 254 · cited 2×
“Antidepressants such as selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs), or noradrenergic and specific serotonergic antidepressants (NASSAs) have potential usefulness for the management of others symptoms [Loprinzi et al., 1998; Tasmut et al., 2002], and they are o…”
BackgroundDepression in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Pilot Study
Pirl, W. F., Siegel, G. I., Goode, M. J., & Smith, M. R. (2002) · Psycho-Oncology · doi:10.1002/pon.592 · Cited by 149 · cited 2×
“This finding is consistent with other studies specifically aimed at estimating the prevalence of major depressive disorder [Pirl et al., 2002; Sharpe et al., 2004] or adjustment disorders in patients with cancer [Atesci et al.”
ResultRelevance of anger and irritability in outpatients with major depressive disorder
Pasquini, M., Picardi, A., Biondi, M., Gaetano, P., & Morosini, P. (2004) · Psychopathology · doi:10.1159/000079418 · Cited by 85 · cited 1×
“The HARS is an established scale to assess anxiety symptoms, and the SVARAD, 10-item instrument specifically developed for the rapid assessment of the main psychopathological dimensions, has been validated and used in several research projects [Pasquini et al., 2004; Picardi et al., 2004].”
MethodSelf-citation
Cited by
Anxiety disorders and comorbid medical illness
Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., Asmundson, G. J. G., Goodwin, R. D., Kubzansky, L., Lydiard, R. B., Massie, M. J., Katon, W., Laden, S. K., et al. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.12.006 · Cited by 668
Screening for Distress and Unmet Needs in Patients With Cancer: Review and Recommendations
Carlson, L. E., Waller, A., & Mitchell, A. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5509 · Cited by 550
Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis
Singer, S., Das-Munshi, J., & Brähler, E. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp515 · Cited by 392
“Since psychiatric conditions in cancer patients have been shown to be easily managed with psychotherapy [33, 34], pharmacotherapy [35], or a combined approach [36], their identification is crucial, preferably at an early stage of oncological treatment [37].”
BackgroundDiurnal cortisol rhythm as a predictor of lung cancer survival
Sephton, S. E., Lush, E., Dedert, E. A., Floyd, A. R., Rebholz, W. N., Dhabhar, F. S., Spiegel, D., & Salmon, P. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.07.019 · Cited by 309
Metadata
- Authors
- Pasquini, M., Biondi, M., Costantini, A., Cairoli, F., Ferrarese, G., Picardi, A., & Sternberg, C.
- Venue
- Depression and Anxiety
- Publisher
- Hindawi Limited
- Published
- 2006
- Volume
- 23
- Issue
- 7
- Pages
- 441-448
- ISSN
- 1091-4269 (ISSN-L)
- 1520-6394
- OpenAlex
- W2002704043
- Cited by
- 56
- References
- 7
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division. https://app.cochat.ai/papers/10.1002/da.20198
- The paper
- Pasquini, M., Biondi, M., Costantini, A., Cairoli, F., Ferrarese, G., Picardi, A., & Sternberg, C. (2006). Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division. Depression and Anxiety. https://doi.org/10.1002/da.20198
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.